Knowledge Center
Poster / Oct 18, 2021
Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release
Source:
AAPS 2021
Track: Formulation and Delivery 鈥 Chemical
Monday, October 18, 2021 | 12:30 PM 鈥 1:30 PM ET听
听
听 听 |
Presenting Author:听Beatriz Noriega-Fernandes听-听Scientist, Inhalation and Advanced Drug Delivery Group, R&D
听
Although drug delivery to the lung presents several advantages, its therapeutic efficiency is limited by a rapid clearance. Thus, this poster presentation will focus on the development of sustained release formulations suitable for lung delivery.听 The main goal will be to assess the impact of encapsulating a model drug (fluticasone propionate, FP) in 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) vesicles prior to spray-drying (SD) on the final product aerodynamic performance and dissolution.
听
听
听
听
Also in the Knowledge Center
/ May 03, 2022
Use of PAT tools in the development, monitor and control of continuous manufacturing processes
Read more
Scientific Article
/ May 03, 2022
Enhancing the 鈥渞ight first time鈥 concept in Continuous Manufacturing 鈥 Development strategy
Read more
Scientific Article
Scientific Article